Aging Dis. 2024 Oct 1;15(5):2241-2254. doi: 10.14336/AD.2024.0224.
This study aims to investigate two key aspects in a mouse model of ocular hypertension (OHT): first, the time course of retinal ganglion cell (RGC) death and the parallel activation of caspase-3 (a-Casp3+ cells) to narrow the therapeutic window; and second, the effect of caspase-3 and microglia inhibition by minocycline on RGC rescue in this model. RGC loss after OHT induction was significant at day 7 and progressed to 30 days. However, anatomical RGC death was preceded by significant Casp3 activation on day 3. Microglial inhibition by minocycline did not alter the course of OHT or rescue RGCs but resulted in a decrease in a-Casp3+ cells and phagocytic and total microglia. Therefore, RGC death commitment occurs earlier than their loss of Brn3a expression, microglial cells do not exacerbate RGC loss, and while this death is primarily apoptotic, apoptosis inhibition does not rescue RGCs, suggesting that alternative death pathways play a role in glaucomatous injury.
本研究旨在探讨眼高压(OHT)小鼠模型中的两个关键方面:首先,视网膜神经节细胞(RGC)死亡的时间进程和 caspase-3 的平行激活(a-Casp3+细胞)以缩小治疗窗口;其次,半胱天冬酶-3 抑制和米诺环素对该模型中 RGC 挽救的影响。OHT 诱导后 RGC 损失在第 7 天显着,并进展至第 30 天。然而,解剖学 RGC 死亡之前 Casp3 激活显着在第 3 天。米诺环素抑制小胶质细胞不会改变 OHT 的过程或挽救 RGC,但导致 a-Casp3+细胞和吞噬和总小胶质细胞减少。因此,RGC 死亡承诺发生在其 Brn3a 表达丧失之前,小胶质细胞不会加剧 RGC 丧失,并且虽然这种死亡主要是凋亡,但凋亡抑制不能挽救 RGC,表明替代死亡途径在青光眼损伤中起作用。